Antitumor effect of N-succinyl-chitosan nanoparticles on K562 cells

Biomedicine and Pharmacotherapy

Volumn 64, Issue 8, 2010, Pages 521-526

  Luo, Huiying ^a   Li, Juan ^b   Chen, Xuan ^b  

^a GANSU UNIVERSITY OF CHINESE MEDICINE   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; N succinyl chitosan nanoparticles; Necrosis

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM ION; CHITOSAN DERIVATIVE; DNA; N SUCCINYL CHITOSAN NANOPARTICLE; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN K 562; CELL STRUCTURE; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG INHIBITION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIUM; CELL CULTURE TECHNIQUES; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CHITOSAN; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; K562 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; NANOPARTICLES; NECROSIS; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; SURFACE PROPERTIES;

EID: 77956882724     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.09.002     Document Type: Article

References (33)

1. Smets A. Programmed cell death (apoptosis) and response to anti-cancer drugs. Anticancer Drugs 1994, 5:3-9.
2. Langer R. Biomaterials in drug delivery and tissue engineering: One laboratory's experience. Accounts Chem Res. 2000, 33:94-101.
3. Barraud L., Merle P., Soma E., et al. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepatol 2005, 42:629-631.
4. Sudarshan N.R., Hoover D.G., Knorr D. Antibacterial action of chitosan. Food Biotechnol 1992, 6:257-272.
5. Tsai G.J., Su W.H. Antibacterial activity of shrimp chitosan against Escherichia coli. J Food Prot 1999, 62:239-243.
6. Janes K.A., Fresneau M.P., Marazuela A., Fabra A., Alonso M.J. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Rel 2001, 73:255-267.
7. De Campos A.M., Sanchez A., Alonso M.J. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosorin A. Int J Pharm 2001, 224:159-168.
8. Xu Y., Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm 2003, 250:215-226.
9. Qi L., Xu Z., Jiang X., Hu C., Zou X. Preparation and antibacterial activity of chitosan nanoparticles. Carbohyd Res. 2004, 339:2693-2700.
10. Qi L., Xu Z., Jiang X., Li Y., Wang M. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorg Med Chem Lett 2005, 15:1397-1399.
11. Qi L., Xu Z., Li Y., Jiang X., Han X. In vitro effects of chitosan nanoparticles on growth of human gastric cancer cell line MGC803 cells. World J Gastroentero 2005, 11:5136-5141.
12. Qi L., Xu Z. In vivo antitumour activity of chitosan nanoparticles. Bioorg Med Chem Lett 2006, 16:4243-4245.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
14. Peters P.J., Geuze H.J., Van der Donk H.A., Slot J.W., Griffith J.M., Stam N.J., et al. Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur J Immunol 1989, 19:1469-1471.
15. Hermann M., Lorenz H.M., Voll R., Grunke M., Woith W., Kalden J.R. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 1994, 22:5506-5507.
16. Konstantinov S.M., Topashka-Ancheva M., Benner A., Berger M.R. Alkylphosphocholines: effects on human leukemic cell lines and normal bone marrow cells. Int J Cancer 1998, 77:778-796.
17. Subhashini J., Mahipal S.V.K., Reddanna P. Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro. Cancer Lett 2005, 224:31-43.
18. McLaughlin S. The electrostatic properties of membranes. Ann Rev Biophys Biophys Chem 1989, 18:113-136.
19. Kim H., You S., Kong B.W., Foster L.K., Farris J., Foster D.N. Necrotic cell death by hydrogen peroxide in immortal DF-1 chicken embryo fibroblast cells expressing deregulated MnSOD and catalase. Biochim Bioph Acta 2001, 1540:137-146.
20. Buyukavci M., Ozdemir O., Buck S., Stout M., Ravindranath Y., Savasan S. Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect. Fundam Clin Pharmacol 2006, 20:73-79.
21. Kok Y.J., Swe M., Sit K.H. Necrosis has orderly DNA fragmentations. Biochem Bioph Res Co 2002, 294:934-939.
22. Ahsan F., Rivas I.P., Khan M.A., Torres Suarez A.I. Targeting to macrophages: Role of physicochemical properties of particulate carriers-liposomes and microspheres on the phagocytosis by macrophages. J Control Release 2002, 79:29-40.
23. Dellacherie E., Gref R., Quellec P.S. Nanospheres as new injectable drug carriers: A promising way? MS-Medicine Sci 2001, 17:619-626.
24. Johnson O.L., Cleland J.L., Lee H.J., et al. A month-long effect from a single injection of microencapsulated human growth hormone. Nat Med 1996, 3:795-799.
25. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462.
26. Marchetti P., Castedo M., Susin S.A., Zamzami N., Hirsch T., Macho A., et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 1996, 184:1155-1160.
27. Kroemer G., Dallaporta B., Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol. 1998, 60:619-642.
28. Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssiere J.L., Petit P.X., et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995, 374:1661-1672.
29. Binggeli R., Weinstein R.C. Membrane potentials and sodium channels: hypotheses for growth regulation and cancer formation based on changes in sodium channels and gap junctions. J Theor Biol 1986, 123:377-401.
30. Annarosa A., Carla M., Del Bene M., Becchetti A., Wanke E., Olivotto M. Polar/apolar compounds induce leukemia cell differentiation by modulating cell-surface potential. Proc Natl Acad Sci U S A 1993, 90:5858-5862.
31. Yano H., Mizoguchi A., Fukuda K., Haramaki M., Ogasawara S., Momosaki S. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res. 1994, 54:448-454.
32. Tseng C.J., Wang Y.J., Liang Y.C., Jeng J.H., Lee W.S., Lin J.K. Microtubule damaging agents induce apoptosis in HL 60 cells and G2/M cell cycle arrest in HT 29 cells. Toxicology 2002, 175:123-142.
33. Kang C.D., Yoo S.D., Hwang B.W., Kim K.W., Kim D.W., Kim C.M., et al. The inhibition of ERK/MAPK not the activation of JNK/SAPK is primarily required to induce apoptosis in chronic myelogenous leukemic K562 cells. Leuk Res 2000, 24:527-534.